Cargando…
Resistance to DNA-damaging treatment in non-small cell lung cancer tumor-initiating cells involves reduced DNA-PK/ATM activation and diminished cell cycle arrest
Increasing evidence suggests that tumor-initiating cells (TICs), also called cancer stem cells, are partly responsible for resistance to DNA-damaging treatment. Here we addressed if such a phenotype may contribute to radio- and cisplatin resistance in non-small cell lung cancer (NSCLC). We showed th...
Autores principales: | Lundholm, L, Hååg, P, Zong, D, Juntti, T, Mörk, B, Lewensohn, R, Viktorsson, K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3563998/ https://www.ncbi.nlm.nih.gov/pubmed/23370278 http://dx.doi.org/10.1038/cddis.2012.211 |
Ejemplares similares
-
Harnessing the lysosome-dependent antitumor activity of phenothiazines in human small cell lung cancer
por: Zong, D, et al.
Publicado: (2014) -
DKK1 is a potential novel mediator of cisplatin-refractoriness in non-small cell lung cancer cell lines
por: Salim, Hogir, et al.
Publicado: (2015) -
EPHA2 Interacts with DNA-PK(cs) in Cell Nucleus and Controls Ionizing Radiation Responses in Non-Small Cell Lung Cancer Cells
por: Kaminskyy, Vitaliy O., et al.
Publicado: (2021) -
AZD-7648, a DNA-PK Inhibitor, Induces DNA Damage, Apoptosis, and Cell Cycle Arrest in Chronic and Acute Myeloid Leukemia Cells
por: Lapa, Beatriz Santos, et al.
Publicado: (2023) -
ALDOA inhibits cell cycle arrest induced by DNA damage via the ATM-PLK1 pathway in pancreatic cancer cells
por: Chen, Haidi, et al.
Publicado: (2021)